Disease Models & Mechanisms
Disease Models & Mechanisms is a monthly peer-reviewed Open Access biomedical journal published by The Company of Biologists that launched in 2008. DMM is part of the Review Commons initiative, is integrated with bioRxiv for co-submission and is partnered with the Web of Science Reviewer Recognition Service.
Scope and content
DMM publishes original research, resources and reviews that focus on the use of model systems to better understand, diagnose and treat human disease.Model systems of interest include:
- Vertebrates such as mice, zebrafish, frogs, rats and other mammals
- Invertebrates such as Drosophila melanogaster and Caenorhabditis elegans
- Unique in vitro or ex vivo models, such as stem-cell-based models, organoids and systems based on patient material
- Microorganisms such as yeast and Dictyostelium
- Other biological systems with relevance to human disease research
- Cancer
- Neurodegenerative and neurological diseases
- Psychiatric disorders
- Metabolic disorders, including diabetes and obesity
- Cardiovascular diseases, stroke and hypertension
- Gastrointestinal diseases
- Infectious diseases
- Autoimmunity and inflammation
- Developmental diseases
- Musculoskeletal disorders
- Renal or liver disease
- Eye disorders
- Drug and biomarker discovery/screening
- Stem cell therapies in regenerative medicine
All papers are published as Open Access articles under the CC-BY licence.
Abstracting and indexing
The journal is abstracted and/or indexed by:- BIOBASE
- CAB abstracts
- Cambridge Scientific Abstracts
- Clarivate Analytics Web of Science
- EMBASE
- Medline
- Scopus
Disease Models & Mechanisms is a signatory of the San Francisco Declaration on Research Assessment (DORA).
Management
The founding editor-in-chief was Vivian Siegel, followed by Ross Cagan and Monica J. Justice.Elizabeth Patton was appointed Editor-in-Chief in December 2020, with Elaine Mardis as Deputy Editor-in-Chief.